Dr. Frank Pun, Ph.D. MBA
- Head of Hong Kong Office, Insilico Medicine
Dr. Frank Pun is the Head of the Hong Kong Office at Insilico Medicine, where he leads a team of application scientists focused on the AI-driven biological target discovery platform, PandaOmics. His primary objective is to provide cutting-edge AI technology to scientists, medical professionals, biotechnology firms, and pharmaceutical companies worldwide, enabling them to identify actionable therapeutic targets and expedite the process of drug discovery and development.
Frank received his Ph.D. in biochemistry from the Hong Kong University of Science and Technology in 2010. Following his graduation, he served as a visiting scholar, leading a team dedicated to studying human CNS diseases and cancer for several years. In 2019, he also obtained an MBA from Rutgers Business School in the United States.
Throughout his career, Frank has made significant contributions to target discovery, publishing numerous impactful papers in the field. He is recognized as a key opinion leader in his respective domain.